| abstract |
FORMULATION OF HETEROCYCLICAL COMPOUNDS, METHOD TO TREAT INFLAMMATORY OR ALLERGIC CONDITIONS AND SUBSTANTIALLY PURE AMORPIAN FORM OF A COMPOUND. The present invention relates to bioavailable pharmaceutical formulations of heterocyclic compounds, such as N (3,5-dichloropyrid-4-yl) -4-difluoromethoxy-8-rethanesulfonamido-dibenzo [b, d] furan-l-carboxamide (oglemilast ) and their pharmaceutically acceptable salts, processes for their preparation and treatment methods using them. The present invention also relates to substantially pure amorphous forms of heterocyclic compounds, such as oglemilast. The invention particularly relates to bioavailable pharmaceutical oral dosage forms containing amorphous oglemilast. |